NYTech
Companies
Companygenerative ai

Numenos AI

Numenos was founded on the insight that biology lacks the foundational laws that make physics predictive, and we lack the tools to discover them. Medicine today treats diseases as separate, isolated problems. Cancer researchers study cancer. Autoimmune specialists study autoimmune disease. Neurologists study neurological conditions. Each operates in its own silo, learning correlations specific to their disease without discovering the deeper principles that connect them all. This lack of underst[1][2]

Visit website Suggest an update
2023 Founded13 People on the graph

Overview

Numenos AI is a company operating in the New York artificial intelligence scene[1]. Founded in 2023[2], the company operates in the biotechnology research industry[3]. Numenos was established on the premise that biology lacks the foundational laws that make physics predictive, and that tools to discover such laws are currently unavailable[2]. According to the company's stated perspective, medicine today treats diseases as separate, isolated problems, with cancer researchers, autoimmune specialists, and neurologists each operating in distinct silos and learning correlations specific to their respective diseases without discovering deeper connecting principles[2]. The company has 19 employees[3].

Business address: 244 5th Avenue, New York, New York, 10001. [5]

Growth & traction

LinkedIn lists 19 people working at Numenos AI. [4]

Leadership & org chart

Alumni

Something wrong or missing? Send an update. Fixed within 24 hours.